Jodie Dodd

Professor Jodie Dodd

Professor

Adelaide Medical School

Faculty of Health and Medical Sciences

Eligible to supervise Masters and PhD - email supervisor to discuss availability.


Professor Jodie Dodd is an obstetrician, maternal fetal medicine specialist and Practitioner Fellow at the Women’s and Children’s Hospital and a clinical researcher at the University of Adelaide. She leads a multi-disciplinary research group including students, and is an international authority on obesity during pregnancy and early life approaches to obesity prevention.

Professor Dodd's research is driven to ensure that care for women and their infant’s is effective, and that treatment benefits outweigh harms. Randomised trials, systematic reviews and meta-analyses remain the gold standard research methodology for establishing the effects of different forms of care.

Professor Dodd currently holds a NHMRC Practitioner Fellowship, and prior to that a Neil Hamilton Fairley Fellowship, which enabled post-doctoral work to be undertaken through the University of Toronto, Canada. She is editor for the Pregnancy and Childbirth Group of the Cochrane Collaboration and past Chair of the South Australian Maternal and Neonatal Clinical Network.

In recognition of her outstanding contributions to the field, Professor Dodd was awarded an L2 Investigator Grant from the NHMRC (2021-2025) for her project "Healthy diet and weight management in pregnancy: evidence to ease a hefty clinical burden".

 

In Australia, 64% of adults and a quarter of children are overweight or obese; almost one in three suffer from hypertension, and one in twenty has diabetes. Obesity, hypertension, and diabetes are powerful independent risk factors for cardiovascular disease, all of which have been identified by NHMRC as national health priority areas. Obesity affects 50% of pregnant women, and is associated with an increased risk of adverse pregnancy and birth outcomes. In the longer-term, maternal obesity is a significant predictor of high infant birth weight, and future child obesity.

Professor Dodd has successfully led the LIMIT RCT (APP519240), the largest trial of its kind evaluating the effect of an antenatal dietary and lifestyle intervention in 2,212 overweight or obese pregnant women on maternal and infant health. While women improved their dietary and physical activity behaviours, there was no effect on GWG, or clinical pregnancy outcomes (BMJ 2014). The intervention significantly reduced the chance of birth weight >4kg, though this effect does not appear to be sustained at longer-term child follow-up assessments, with up to 46% of children at 18 months of age having BMI above the 85th centile. We have completed assessment of the children and 3-5 years of age and will report these findings soon. Follow up of the children at 8-10 years is commencing in 2019.

The findings of the findings of the LIMIT RCT have since been confirmed by other researchers in the field, and on a global scale, by the International Weight Management in Pregnancy (i-WIP) collaboration. This individual participant data (IPD) meta-analysis comprised 36 RCTs and more than 12,500 pregnant women who received a dietary and/or lifestyle intervention and demonstrated a modest effect on GWG (mean difference 0.7kg), but little effect on clinical outcomes.

 

Current Projects

The Begin Better Randomised Trial

MRFF ID 1199789

Maternal health and the first 2000 days of a child’s life, from conception until their 5th birthday, are identified as critical for an individual’s long term health and well-being.

Infants born to women who are overweight or obese are more likely to have birth weight above 4.0kg. Almost 50% of women are overweight or obese on entering pregnancy. The impact of both maternal obesity and high birth weight extends beyond birth and are independently associated with an increased chance of early childhood obesity.

Our findings, from previous work, show that while dietary and lifestyle intervention in pregnancy improves maternal diet and physical activity behaviours, there is no effect on gestational weight gain (GWG), pregnancy and birth outcomes, or risk of child obesity. These findings have subsequently been replicated by others internationally. Importantly, our previous findings show that the strongest and most consistent predictor of child obesity is maternal pre-pregnancy BMI. This is an important, potentially modifiable factor impacting pregnancy, birth and child health outcomes that warrants robust evaluation through a weight loss intervention prior to pregnancy.

We will enroll approximately 800 women who are planning pregnancy in a randomised trial of a weight loss intervention before conception. We will follow the women and obtain pregnancy outcome data for women who become pregnant. Our primary outcome is birth weight of 4kg or more, an important risk factor for later childhood obesity.

 

The single dose of antenatal corticosteroids (SNACS) randomised trial for women at risk for preterm birth.

MRFF ID 2015329

Globally, each year 15 million babies are born preterm, <37 weeks. For babies at high risk of pre-term birth, in utero exposure to a standard two doses (administered 24 hours apart) of antenatal corticosteroids (ACS) improves fetal lung and brain development thus reducing preterm infant mortality & morbidity. However, ACS is associated with side effects such as adverse neurosensory, cognitive, cardiovascular and renal outcomes. While the benefits of ACS outweigh the risks for babies born <35 weeks, for those exposed to ACS who go on to full term birth the risks and impact of side effects are significant.

Despite ACS being used since the 1970s, the optimal dose has never been determined. Based on animal studies and limited evidence from human studies, we hypothesise that a single dose of ACS is sufficient for lung maturation in pre-term babies but has an improved side effect profile.
We will perform a multi-centre randomised clinical trial involving 1560 Australian women and babies at risk of pre-term birth, assigned to either the standard dose of ACS or to a single dose ACS (plus placebo). The primary outcome will be a composite of mortality or substantial morbidity. Secondary outcomes include neurosensory, developmental and behavioural impairment to measure whether the single ACS dose has an improved side effect profile and will be measured at the time of hospital discharge and again at 2 years of age.

This project is part of an international trial partnership led by the Population Health Research Institute in Canada and will be the first to determine the effects of single dose ACS for babies at risk of pre-term birth. Our highly experienced team will enable rapid translation of these results into clinical practice across Australia and deliver profound economic and health improvements for individuals, families and the broader community.

 

The First 1,000 Days: in-utero and early life exposures and their contribution to child obesity.

NHMRC, ID 1159338

Professor Dodd and her research group will evaluate the cardiometabolic, inflammatory, and epigenetic pathways linking maternal and intrauterine factors to newborn and childhood adiposity and obesity. Utilizing their uniquely harmonized, large-scale clinical trials and related bio-bank specimens they will evaluate dietary and lifestyle interventions (including metformin) in pregnant women across the BMI spectrum. The included trials are the LIMIT RCT evaluating dietary intervention vs standard antenatal care in 2,212 pregnant women with BMI ≥ 25kg/m2; the GRoW RCT evaluating metformin in addition to dietary and lifestyle advice in 524 pregnant women with BMI ≥ 25kg/m2; and the OPTIMISE RCT evaluating a dietary intervention versus standard care in 640 pregnant women; BMI 18.5-24.9kg/m2. All of these trials include follow up of the children at 6 and 18 months and 3-5 years of age. These trials offer unique power and capability, due to their large scale, intervention based design, randomization and longer-term follow-up into childhood.

This grant will facilitate follow up of the children from the LIMIT RCT at 8-10 years of age, commencing in 2019.

BMC Pediatrics https://doi.org/10.1186/s12887-023-04466-4

 

Recently reported research

The effects of dietary and lifestyle interventions among pregnant women who are overweight or obese on longer-term maternal and early childhood outcomes: an individual participant data (IPD) meta-analysis

(NHMRC, ID 1143773)

Professor Dodd and her research group have a unique opportunity to evaluate the effect of antenatal dietary intervention among women who are overweight or obese on longer-term maternal and child health through conducting an individual participant data meta-analysis (IPDMA).

Professor Dodd and her research have contributed to the successful completion of the international Weight management In Pregnancy (i-WIP) IPDMA to assess the effects of antenatal dietary and lifestyle interventions on pregnancy outcomes. Many of the included studies have followed women and their infants who participated in the pregnancy intervention studies into childhood. We will use IPDMA methodology to evaluate the effect of dietary and lifestyle interventions in pregnancy on the longer term health of women and their babies. Professor Dodd will lead this longer term follow up in collaboration with partners across Europe, who have evaluated the longer term impact of pregnancy interventions within their own pregnancy intervention studies.

In overweight and obese pregnant women, we found no evidence that maternal dietary and/or lifestyle intervention during pregnancy modifies the risk of early childhood obesity. Future research may need to target the pre-conception period in women and early childhood interventions.

BMC Medicine https://doi.org/10.1186/s12916-021-01995-6

Optimising gestational weight gain and improving maternal and infant health outcomes through antenatal dietary, lifestyle and physical activity advice: the OPTIMISE randomised controlled

Obesity represents a significant health burden and the World Health Organisation recognises the importance of preventing weight gain and subsequent development of obesity among adults who are within the healthy weight range. Women of reproductive age have demonstrated high rates of weight gain during pregnancy placing them at risk of becoming overweight or obese. Professor Dodd and her research group are evaluating the effects of dietary and physical activity advice on maternal, fetal and infant health outcomes, among pregnant women of normal body mass index (BMI).

The trial was conducted in Adelaide, South Australia. Pregnant women with a body mass index in the healthy weight range (18.5–24.9 kg/m2) were enrolled in a randomised controlled trial of a dietary and lifestyle intervention versus standard antenatal care. The dietitian-led dietary and lifestyle intervention over the course of pregnancy was based on the Australian Guide to Healthy Eating. Baseline characteristics of women in the two treatment groups were similar. There was no statistically significant difference in the proportion of infants with birth weight above 4.0 kg between the Lifestyle Advice and Standard Care groups (24/316 (7.59%) Lifestyle Advice versus 26/313 (8.31%) Standard Care; adjusted risk ratio (aRR) 0.91; 95% confidence interval (CI) 0.54 to 1.55; p = 0.732). Despite improvements in maternal diet quality, no significant differences between the treatment groups were observed for total GWG, or other pregnancy and birth outcomes.

Nutrients https://doi.org/10.3390/nu11122911

Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial

(NHMRC, ID 1043181)

The aim of this randomised trial was, for the first time, to evaluate the effects of antenatal metformin as an adjuvant therapy to dietary and lifestyle advice among overweight and obese pregnant women on maternal and infant outcomes.

Pregnant women with BMI above 25kg/m2, at their first antenatal visit, were randomly allocated to receive either metformin to a maximum dose of 2000mg per day, or an identical appearing placebo, using a computer generated schedule. All women received an antenatal dietary and lifestyle intervention across the course of pregnancy. The primary outcome was the proportion of infants with birthweight above 4000grams. Secondary outcomes included gestational weight gain (GWG), maternal pregnancy, labour and birth, and infant outcomes.

In the largest pregnancy study to date evaluating metformin, 524 women were randomised (261 Metformin; 263 Placebo). There was no significant difference in the proportion of infants with birthweight above 4000g. While women who received metformin had lower weekly gestational weight gain and were more likely to have weight gain below the Institute of Medicine recommendations, total gestational weight gain was not statistically significantly different between the two treatment groups. The use of metformin was not associated with any evidence of impact on pregnancy and birth outcomes.

Although these findings provide some evidence that metformin as an adjuvant therapy to a dietary intervention in overweight and obese pregnant women reduces some measures of gestational weight gain, there was no evidence of an impact on pregnancy and birth outcomes. Use of metformin in this clinical setting is not advocated.

https://www.thelancet.com/journals/landia/article/PIIS2213-8587(18)30310-3/fulltext

Nutrition During Pregnancy, Lactation and Early Childhood and its Implications for Maternal and Long-Term Child Health: The Early Nutrition Project Recommendations

Koletzko B, Godfrey KM, Poston L, Szajewska H, van Goudoever JB, · de Waard M, Brands B, · Grivell RM, Deussen AR, Dodd JM, Patro-Golab B, Zalewski BM, EarlyNutrition Project Systematic Review Group.

A considerable body of evidence accumulated especially during the last decade, demonstrating that early nutrition and lifestyle have long-term effects on later health and disease (“developmental or metabolic programming”).

Researchers involved in the European Union funded international EarlyNutrition research project consolidated the scientific evidence base and existing recommendations to formulate consensus recommendations on nutrition and lifestyle before and during pregnancy, during infancy and early childhood that take long-term health impact into account. Systematic reviews were performed on published dietary guidelines, standards and recommendations, with special attention to long-term health consequences. In addition, systematic reviews of published systematic reviews on nutritional interventions or exposures in pregnancy and in infants and young children aged up to 3 years that describe effects on subsequent overweight, obesity and body composition were performed. Experts developed consensus recommendations incorporating the wide-ranging expertise from additional 33 stakeholders.

Most current recommendations for pregnant women, particularly obese women, and for young children do not take long-term health consequences of early nutrition into account, although the available evidence for relevant consequences of lifestyle, diet and growth patterns in early life on later health and disease risk is strong. Interpretation: This work presents updated recommendations for optimized nutrition before and during pregnancy, during lactation, infancy and toddlerhood, with special reference to later health outcomes. These recommendations are developed for affluent populations, such as women and children in Europe, and should contribute to the primary prevention of obesity and associated non-communicable diseases.

 

https://www.karger.com/Article/FullText/496471

  • Appointments

    Date Position Institution name
    2019 - ongoing Head of Discipline The University of Adelaide
    2019 - ongoing Head of Department The University of Adelaide
    2019 - ongoing Clinical Director Medical Women's and Children's Hospital
    2019 - 2019 Director of Obstetrics Women's and Children's Hospital
    2010 - ongoing Professor (Level E) University of Adelaide
    2009 - 2010 Associate Professor University of Adelaide
    2008 - 2009 Senior Lecturer University of Adelaide
    2006 - 2009 National Health and Medical Research Council (NHMRC) Neil Hamilton Fairley Overseas Clinical Fellow The University of Adelaide and The University of Toronto
    2005 - ongoing Maternal Fetal Medicine Specialist Women’s and Children’s Hospital
    2001 - 2004 Locum Maternal Fetal Medicine Specialist and Subspecialty Trainee Women's and Children's Hospital
    2000 - ongoing Senior Obstetric Registrar Women's and Children's Hospital
    1999 - ongoing Registrar Obstetrics & Gynaecology Alice Springs Hospital & Flinders Medical Centre
    1998 - ongoing Registrar Obstetrics & Gynaecology Flinders Medical Centre
    1997 - ongoing Registrar Obstetrics & Gynaecology Lyell McEwin Hospital
    1996 - ongoing Registrar Obstetrics & Gynaecology Modbury Hospital
    1995 - ongoing Resident Medical Officer Queen Elizabeth Hospital
    1994 - ongoing Intern Queen Elizabeth Hospital
  • Awards and Achievements

    Date Type Title Institution Name Country Amount
    2017 Award Society for Maternal Fetal Medicine Award for Research Excellence: Annual Scientific Meeting Society Fetal Medicine United States -
    2015 Fellowship NHMRC Practitioner Fellowship - - -
    2013 Award 2012/2013 David Liu Prize - - -
    2010 Fellowship NHMRC Practitioner Fellowship - - -
    2006 Fellowship NHMRC Neil Hamilton Fairley Clinical Fellowship - - -
    2005 Award Robert Seamark Postgraduate Award The University of Adelaide - -
    2005 Fellowship TG Wilson Travelling Fellowship The University of Adelaide - -
    2005 Award RANZCOG Young Investigator Award - - -
    2004 Fellowship Beresford Buttery Travel Fellowship - - -
    2004 Award North American Perinatal Research Society, International Young Investigator Award - Canada -
    2002 Award PSANZ Young Investigator (Obstetrics) Award - - -
    2000 Award Inaugural John O’Loughlin Medal - - -
    2000 Award Schering Prize - - -
    1996 Award Schering Prize - - -
  • Education

    Date Institution name Country Title
    2005 University of Adelaide Australia Doctor of Philosophy
    2002 Royal Australian & New Zealand College Obstetricians & Gynaecologists (FRANZCOG) Australia Fellow
    1993 University of Adelaide Australia Bachelor of Medicine & Bachelor of Surgery (MBBS)
  • Postgraduate Training

    Date Title Institution Country
    2003 Diploma in Diagnostic Ultrasound (DDU) Australian Society for Ultrasound in Medicine Australia
  • Certifications

    Date Title Institution name Country
    2004 Certification in Maternal Fetal Medicine (CMFM) Royal Australian & New Zealand College Obstetricians & Gynaecologists (RANZCOG) -
  • Research Interests

Research Grants

Career total: 38 grants (6 International competitive including US National Institutes of Health, European Union, JDRF, and Canadian Institute of Health Research); 23 National competitive including 10 NHMRC Project Grants, 2 NHMRC Centre for Research Excellence, and 2 MRFF Project Grant; 6 State competitive)

Total funding: $47,654,388

International Competitive Grants
2016 Canadian Institutes of Health Research (CIHR) Knowledge Synthesis Grant - Knowledge Synthesis Operating Grant. Primary Prevention of Preterm Birth: a Systematic Review and Network Meta-Analysis.  McDonald SD, Mundle W, Barrett J, Beyene J, Biringer A, Chamberlain J, Cook J, Dodd JM, Giglia L, Gulmezoglu M, Han Z, Hebert E, Lopez-Yarto M, Sabatino L, Shah P, Saito S, Staub K, Vera C. $100,000
2015 - 2017

Helmsley Charitable Trust & Juvenile Diabetes Research Fund (JDRF) T1D Clinical Research Network

Couper J, Harrison L, Craig M, Morahan G, Colman P, Wentworth J, Papenfuss A, Rawlinson W, Dodd JM, Giles L

Protection of pancreatic beta cells

$8,006,375
2008 - 2011

National Institute of Health (NIH) (ID R01 HL094235-01))

Gillman M, Dodd J, Crowther C, Owens J

Limiting weight gain in pregnancy: effect on mother and child

$1,313,377 (US)
2007 - 2008

(The Physicians Services Incorporated Foundation (PSI) Ontario, Canada)

Dodd JM, Kingdom JPC, McLeod A, Windrim RC

Does heparin improve pregnancy outcomes for women with evidence of placental dysfunction? – A randomized trial

$121,000 (CAN)

 

National Competitive Grants – NHMRC
2022-2027

(MRFF ID 2015329)

Dodd JM, Poprzeczny A, Keir A, Louise J, O'Brien C, Henry A, Said J, Briley A, Murphy K, McDonald S 

The single dose of antenatal corticosteroids (SNACS) randomised trial for women at risk for preterm birth.

$3,025,899
2021-2026

(MRFF ID 1199789)

Dodd JM, Poprzeczny A, Louise J, Keir A, Pham C, Laws R, Briley A, Turnbull D, Campbell K

The Begin Better Randomised trial

$2,790,917
2021-2025

(NHMRC ID 1196133)

Dodd JM.

Healthy diet and weight management in pregnancy: evidence to ease a hefty clinical burden.

$1,705,260
2019-2023

(NHMRC, ID 1159338)

Dodd JM, Pena A, Schoenaker D, Giles L, Hoyo C, Owens J

The First 1,000 days: in-utero and early life exposures and their contribution to child obesity

$2,426,051
2018 -2019

(NHMRC, ID 1143773)

Dodd JM, Louise J, Thangaratinam S

The effects of dietary and lifestyle interventions among pregnant women who are overweight or obese on longer-term maternal and childhood outcomes: an individual participant data (IPD) meta-analysis.

$287,317
2015 - 2019

(NHMRC CRE, ID 1078106)

Couper J, Harrison L, Craig M, Morahan G, Colman P, Wentworth J, Papenfuss A, Rawlinson W, Dodd JM, Giles L

CRE for the protection of pancreatic beta cells

$2,500,000
2104 - 2015

(NHMRC, ID 1068320)

Dodd JM, Owens JA, Grivell RM, Yelland LN, Giles L, Gillman MW, Poston L

Causal pathways from maternal obesity to pregnancy, perinatal & childhood health outcomes

$755,934
2013 - 2017

(NHMRC, ID 1043181)

Dodd JM, Grivell RM, Hague W

Metformin and dietary advice to improve insulin sensitivity and promote gestational restriction of weight in pregnant women who are obese: the GRoW randomised trial

$1,710,437
2013 - 2015

(NHMRC, ID 1043178)

 Dodd JM, McPhee AJ, Moran LJ, Yelland LN, Gillman M, Lawlor D, Robinson JS

 The contribution of maternal obesity and gestational weight gain to preschool child obesity

$673,008
2012 - 2016

(NHMRC CRE, ID 1035530)

Makrides M, Gibson R, Ryan P, Zou S, Dodd JM, McPhee AJ, Umberger W, Mulhausler B, Collins C, Penttila I

                        Food for future Australians

$2,500,000
2011

(NHMRC Equipment Grant)

Dodd JM, Grivell RM, Crowther CA, Robinson JS

Establishment of a fetal well being and ultrasound diagnostic unit

$50,000
2011                

(NHMRC Equipment Grant)

Dodd JM, Grivell RM, Crowther CA, Robinson JS

Newborn and infant body composition assessment unit

$16,000
2010 - 2012

(NHMRC, ID 627195)

Dodd JM, Dickinson J, Andersen C, Windrim RC, Ryan G

Doppler to time second and subsequent fetal blood transfusions for women with red cell alloimmunisation: a randomised trial

$433,750
2010 - 2012  

(NHMRC, ID 627213)

Crowther CA, Dodd JM, McPhee A, Flenady VJ

Vaginal progesterone for the prevention of neonatal respiratory distress syndrome: a randomised trial

$979,369
2010

(NHMRC Equipment Grant, ID 640305)

Dodd JM, Owens JA, Robinson JS, Crowther CA, Pitcher JB, MacLennan AH

Establishment of a biobank and cryogenic storage facility to evaluate mechanistic pathways following interventions during pregnancy to improve maternal, infant and childhood health

$33,000
2008 - 2011

(NHMRC, ID 519240)

 Dodd JM, Turnbull D, McPhee A, Wittert G, Robinson JS

Limiting weight gain in overweight and obese women during pregnancy to improve health outcomes: a randomised trial

$1,466,625
2006 - 2008 

(NHMRC, ID 339137)

Crowther CA, Dodd JM, McPhee A, Flenady VJ

Vaginal progesterone for the prevention of neonatal respiratory distress syndrome: a randomised trial

$1,202,350
2005 - 2007  

(NHMRC, ID 349460)

Crowther CA, Dodd JM, Hiller JE, Haslam RR

Planned vaginal birth or planned elective repeat caesarean for women at term with a single previous caesarean section

$782,250

                    

National Competitive Grants - Medical Research Future Fund
2020-2025

(MRFF ID 1199789)

Dodd JM, Poprzeczny A, Louise J, Keir A, Pham C, Laws R, Briley A, Turnbull D, Campbell K.

The Begin Better Randomised Trial.

$2,790,917
2018-2022

(MRFF, ID 1152418)

Hague W, Dodd JM, Morris J, Stark JM, Peek MJ, Middleton PF, Shand A, Newnham J, Callaway L, Walker SP

Treatment of severe early onset intrahepatic cholestasis of pregnancy.

$1,153,122
National Competitive Grants – Other
2020-2021

(Hospitals Charitable Foundation)

Dodd JM

Variations in clinical practice and health outcomes for women and babies associated with early term caesarean birth in the absence of medical indication.

$161,195
2012 - 2013

(Foundation for Children)

Moran LJ, Dodd JM

Cardioinflammatory markers in neonates born to overweight or obese women

$79,474
2012 - 2013

(Diabetes Australia Research Trust Millenium Grant)

Owens JA, Dodd JM

Identifying epigenetic pathways from maternal obesity to type 2 diabetes in offspring

$158,385
2012

(Diabetes Australia Research Trust Millenium Grant)

Moran L, Dodd JM

Glucose intolerance among overweight and obese women: maternal 3-year follow-up from the LIMIT randomised trial

$34,318
2010 - 2011    

(Clive and Vera Ramaciotti Foundation ID2882/2009)

Dodd JM, Owens JA, Robinson JS

Do maternal and infant obesity related genotypes influence efficacy of interventions to limit weight gain in obese pregnant women and obesity in their offspring?

$50,000
2009 - 2011

(Federal Department of Health and Ageing)

Crowther CA, Dodd JM, Flenady V, Middleton P

The Australian Satellite Group, Cochrane Pregnancy & Childbirth Review Group

$120,000
2005 - 2008

(Federal Department of Health and Ageing)

Crowther CA, Dodd JM, Middleton P

The Australian Satellite Group, Cochrane Pregnancy & Childbirth Review Group

$120,000
2003 - 2004  

(Federal Department of Health and Ageing)

Crowther CA, Dodd JM, Smith CA

The Australian Satellite Group, Cochrane Pregnancy & Childbirth Review Group

$80,000
2001 - 2002        

(Federal Department of Health and Ageing)

Crowther CA, Dodd JM, Smith CA, Mohammed K

The Australian Satellite Group, Cochrane Pregnancy & Childbirth Review Group

$78,000
 
State Competitive Grants
2010 - 2011    

(Channel 7 Children’s Research Foundation ID292)

 Robinson JS, Dodd JM, Owens JA

Do maternal and infant obesity related genotypes influence efficacy of interventions to limit weight gain in obese pregnant women and obesity in their offspring?

$115,000
2009 - 2010   

(Channel 7 Children’s Research Foundation)

Grivell R, Dodd JM

Limiting weight gain in pregnancy: effect on ultrasound assessment of fetal growth

$70,000
2004 

(Women’s and Children’s Hospital Research Foundation)

Dodd JM, Crowther CA, Robinson JS, Haslam RR

Birth After Caesarean Study

$45,000
2004

(Women’s and Children’s Hospital Research Foundation)

Dodd JM, Crowther CA, Robinson JS, Haslam RR

Twins: Timing of Birth at Term   

$45,000
2004

(Women’s and Children’s Hospital Research Foundation)

Crowther CA, Dodd JM, McPhee AJ

Management of Preterm Premature Ruptured Membranes

$45,000
2002

(Women’s and Children’s Hospital Research Foundation)

Dodd JM, Crowther CA, Robinson JS

Misoprostol for the induction of labour at term

$45,000

 

Internal Competitive Grants
2015 Lloyd Cox Obstetrics & Gynaecology Strategic Research Excellence Award $50,000
2016 Lloyd Cox Obstetrics & Gynaecology Strategic Research Excellence Award $65,000

              

Competitive Fellowship Support

Career total: 5 fellowships (4 National competitive including 2 NHMRC Practitioner Fellowships and 1 NHMRC Neil Hamilton Fairley Fellowship; 1 State competitive), totalling $1,433,460

 

National Competitive Fellowships
2015 - 2019 NHMRC Practitioner Fellowship (Level 2) $551,435
2010 - 2014 NHMRC Practitioner Fellowship (Level 1)      $420,875
2006 - 2009 NHMRC Neil Hamilton Fairley Clinical Fellowship $351,150
2001 Mayne Nickless Women’s Health Fellowship (awarded by RANZCOG Research Foundation) $50,000

        

State Competitive Fellowships
2002 - 2003 Women’s and Children’s Hospital Foundation Postgraduate Fellowship $60,000

 

Teaching and Training, including Supervision
Teaching and Training Materials Developed
2008-present  Development and co-ordination of course and materials in critical appraisal and study design for RANZCOG Trainees across Australia and New Zealand
2006-2008   Use of an ultrasound model to teach intervention procedures (amniocentesis, chorionic villous sampling and cordocentesis) to medical students, and junior and senior medical staff within the University of Toronto, including an evaluation of performance before and after simulated training sessions
2005  Co-ordinator of teaching course in clinical research methodology and critical appraisal for the South Australian RANZCOG Trainees

   

Other Contributions to Teaching and Training
The University of Adelaide, Discipline of Obstetrics and Gynaecology
2008-present Lecturer/Tutor and Examiner Human Reproductive Health III
2005  Tutor in Perinatal Ultrasound sessions for 5th year medical students, Discipline of Obstetrics & Gynaecology, The University of Adelaide
2001-present Lecturer/Tutor Human Reproductive Health Part 2 (Case Based Learning sessions for 5th year medical students) Discipline of Obstetrics & Gynaecology, The University of Adelaide
2001-present Examiner clinical long cases and OSCE examinations Human Reproductive Health Part 2 (5th year medical students) Discipline of Obstetrics & Gynaecology, The University of Adelaide
2000-present Clinical Tutor Human Reproductive Health Part 2 (5th year medical students), Discipline of Obstetrics & Gynaecology, The University of Adelaide
2000-present Clinical Tutor Human Reproductive Health Part 1 (1st year medical students), Discipline of Obstetrics & Gynaecology, The University of Adelaide

    

Royal Australian and New Zealand College of Obstetricians & Gynaecologists
2008-present Development and co-ordination of course and materials in critical appraisal and study design for RANZCOG Trainees across Australia and New Zealand
2001-present Lecturer/Tutor South Australian RANZCOG Trainees (research methodology, clinical topics in Maternal Fetal Medicine and High Risk Obstetrics)
2005-present  Co-ordinator of teaching course in clinical research methodology and critical appraisal for the South Australian RANZCOG Trainees

 

Other Educational Workshops
2018 2018 Fetal Medicine Update
2008 Data-monitoring and safety for randomised trials workshop, WOMBAT Collaboration, Melbourne
2008 Developing a protocol for a randomised trial, WOMBAT Collaboration, Brisbane
2008 Developing a protocol for a randomised trial, WOMBAT Collaboration, Gold Coast
2008 Interdisciplinary maternal and perinatal clinical trials (IMPACT) workshop, Gold Coast
2007 Developing a protocol for a randomised trial, WOMBAT Collaboration, Melbourne
2007 Interdisciplinary maternal and perinatal clinical trials (IMPACT) workshop, Melbourne

 

Other Student Supervision

2014

Rebecca Greco (Honours)

Zhou SJ, Greco RL, Grivell R, Louise J, Deussen A, Dodd J, Moran LJ. Awareness of Listeriosis and Methylmercury toxicity public health recommendations and diet during pregnancy. Women Birth. 2019 Feb;32(1):e65-e70. doi: 10.1016/j.wombi.2018.04.005. Epub 2018 Apr 17. PMID: 29678412.

2013

Louise Fraser (Honours)

Moran LJ, Fraser LM, Sundernathan T, Deussen AR, Louise J, Yelland LN, Grivell RM, Macpherson A, Gillman MW, Robinson JS, Owens JA, Dodd JM. The effect of an antenatal lifestyle intervention in overweight and obese women on circulating cardiometabolic and inflammatory biomarkers: secondary analyses from the LIMIT randomised trial. BMC Med. 2017 Feb 14;15(1):32. doi: 10.1186/s12916-017-0790-z. PMID: 28193219; PMCID: PMC5307888.

2010

Izyan Mohamad (Honours)

Dodd JM, Deussen AR, Mohamad I, Rifas-Shiman SL, Yelland LN, Louise J, McPhee AJ, Grivell RM, Owens JA, Gillman MW, Robinson JS. The effect of antenatal lifestyle advice for women who are overweight or obese on secondary measures of neonatal body composition: the LIMIT randomised trial. BJOG. 2016 Jan;123(2):244-53. doi: 10.1111/1471-0528.13796. PMID: 26841217; PMCID: PMC4859433.

2010

Lavern Kannieappan (Honours)

Kannieappan LM, Deussen AR, Grivell RM, Yelland L, Dodd JM. Developing a tool for obtaining maternal skinfold thickness measurements and assessing inter-observer variability among pregnant women who are overweight and obese. BMC Pregnancy Childbirth. 2013 Feb 19;13:42. doi: 10.1186/1471-2393-13-42. PMID: 23418751; PMCID: PMC3583701.

2009

Gosia Szmeja (Honours)

Szmeja MA, Cramp C, Grivell RM, Deussen AR, Yelland LN, Dodd JM. Use of a DVD to provide dietary and lifestyle information to pregnant women who are overweight or obese: a nested randomised trial. BMC Pregnancy Childbirth. 2014 Dec 12;14:409. doi: 10.1186/s12884-014-0409-8. PMID: 25495459; PMCID: PMC4280000.

  • Current Higher Degree by Research Supervision (University of Adelaide)

    Date Role Research Topic Program Degree Type Student Load Student Name
    2022 Principal Supervisor Termination of pregnancy in South Australia: time trends and the impact of pregnancy screening for aneuploidy. Doctor of Philosophy Doctorate Part Time Miss Laura Jayne Slade
  • Past Higher Degree by Research Supervision (University of Adelaide)

    Date Role Research Topic Program Degree Type Student Load Student Name
    2019 - 2022 Co-Supervisor Promoting Lifestyle Change in the Preconception Period: Development of the Begin Better eHealth Intervention Doctor of Philosophy Doctorate Full Time Mrs Jodie Michelle Scott
    2016 - 2022 Principal Supervisor Maternal Overweight and Obesity: Effect on Fetal Growth and Adiposity Doctor of Philosophy Doctorate Full Time Miss Amanda Josephine Poprzeczny
    2014 - 2019 Principal Supervisor The Contribution of Maternal Obesity to Fetal Body Composition Doctor of Philosophy Doctorate Part Time Dr Cecelia Maree Obrien
    2011 - 2013 Principal Supervisor Physical activity during pregnancy among pregnant women who are overweight or obese Doctor of Philosophy Doctorate Full Time Zhixian Sui
    2008 - 2012 Principal Supervisor The Fetal Growth Study A Prospective Cohort Study of Fetal Growth and Body Composition in Overweight and Obese Pregnant Women Doctor of Philosophy Doctorate Full Time Dr Rosalie Grivell
  • Committee Memberships

    Date Role Committee Institution Country
    2018 - ongoing Member new Women's and Children's Hospital Taskforce - Education and Research Women's and Children's Hospital Australia
    2017 - ongoing Chair 2018 Fetal Medicine Update Women's and Children's Hospital and University of Adelaide Australia
    2016 - ongoing Member Clinical Research Sub-Committee South Australian Academic Health Science and Translation Centre -
    2015 - ongoing Member Assigners Academy, NHRMC - -
    2015 - ongoing Member NHMRC Practitioner Fellowship Review Group - -
    2013 - 2024 Chair South Australian Abortion Reporting Committee Government of South Australia Australia
    2013 - 2015 Chair South Australian Maternal, Neonatal and Gynaecology Community of Practice South Australian Government Australia
    2011 - 2015 Chair South Australian State-wide Maternal and Neonatal Clinical Network Steering Committee Government of South Australia, Department of Health -
    2011 - 2013 Member Women’s and Children’s Health Network Government of South Australia, Department of Health -
    2011 - ongoing Chair South Australian Maternal, Perinatal, and Infant Mortality Committee Government of South Australia, Department of Health -
    2011 - ongoing Member National Maternity Council - -
    2011 - 2012 Member NHMRC Practitioner Fellowship Review Group - -
    2009 - ongoing Chair SA Maternity and Neonatal Clinical Reference Work Group developing guidelines for care of obese pregnant patients - -
    2009 - 2012 Member NHRMC Grant Review Panel (Perinatology, Paediatrics, Obstetrics, Reproduction; Clinical Trials) - -
    2009 - 2011 Member World Health Organisation (WHO) Integrated Management of Pregnancy and Childbirth (IMPAC) Review Group - -
    2008 - 2011 Member South Australian State-wide Maternal and Neonatal Clinical Network Steering Committee Government of South Australia, Department of Health -
    2008 - 2010 Secretary Executive Committee of the Perinatal Society of Australia and New Zealand (PSANZ) - -
    2008 - 2010 Chair Executive Committee of the Interdisciplinary Maternal and Perinatal Australasian Clinical Trials (IMPACT) Network - -
    2005 - 2006 Representative Maternal Fetal Medicine Committee Royal Australian and New Zealand College of Obstetricians and Gynaecologists -
    2004 - 2006 Representative SA Pregnancy Website Working Group - -
    2004 - 2006 Representative SA Neonatal Screening Programme - -
    2002 - 2003 Representative Executive Committee of the Interdisciplinary Maternal and Perinatal Australasian Clinical Trials (IMPACT) Network - -
  • Consulting/Advisories

    Date Institution Department Organisation Type Country
    2023 - 2025 World Health Organization Technical Advisory Group reviewing Gestational Weight Gain Recommendations Health services and related Switzerland
    2016 - 2017 International Scientific Advisory Board - - -
    2012 - 2013 Scientific Committee Perinatal Society Australia & New Zealand - - -
    2009 - ongoing Critical Appraisal Workshop - - -
    2009 - ongoing International Society of Fetus as a Patient, - - -
    2009 - ongoing PSANZ - - -
    2008 - 2010 Scientific Committee RANZCOG ASM - - -
    2008 - ongoing RANZCOG - - -
    2008 - ongoing PSANZ - - -
    2002 - ongoing International Society of Perinatal Obstetricians - - -
  • Editorial Boards

    Date Role Editorial Board Name Institution Country
    2008 - ongoing Editor Cochrane Pregnancy and Childbirth Group - -
    2008 - 2013 Associate Editor Australian and New Zealand Journal Obstetrics & Gynaecology - -
    2002 - ongoing Editor Cochrane Pregnancy and Childbirth Review Group - -
    2002 - ongoing Editor general medical journals, including the NEJM, Lancet, British Medical Journal, JAMA, JCEM, Obesity Reviews, International Journal of Obesity, Journal Maternal and Child Health, Journal of the Canadian Medical Association, PLos Medicine, Australian and New Zealand Journal of Public Health, and the Medical Journal of Australia; and specialty journals in Obstetrics and Gynaecology, including Australian and New Zealand Journal of Obstetrics and Gynaecology; European Journal of Obstetrics, Gynecology and Reproductive Biology; British Journal of Obstetrics and Gynaecology; American Journal of Obstetrics and Gynecology; Acta Scandinavica Obstetrica et Gynecologica; Archives of Obstetrics and Gynaecology; American Journal of Perinatology; and Birth - -
  • Event Participation

    Date Event Name Event Type Institution Country
    2017 - 2018 2018 Fetal Medicine Update Symposium Women's and Children's Hospital and The University of Adelaide -
  • Position: Professor
  • Phone: 81617522
  • Email: jodie.dodd@adelaide.edu.au
  • Fax: 81617652
  • Campus: Womens & Childrens Hospital
  • Building: WCH - Queen Victoria Building, floor 1
  • Org Unit: Women's and Children's Health

Connect With Me
External Profiles

Other Links